Skip to content
Back to search results

Premature Infant Pain Profile (PIPP)

Introduced by
Bonnie Stevens
Year
1996
Type
Clinician-rated
Family
procedural-pain-assessment
Font size

What does it do?

The PIPP is a seven-indicator behavioral and physiological pain assessment tool specifically designed for preterm and full-term infants undergoing painful procedures.

Developed by Stevens et al. in 1996, it measures acute procedural pain by integrating gestational age, behavioral state, facial expressions, and vital sign changes. The PIPP has become the most widely validated neonatal acute pain instrument in research and is recommended by major pediatric pain organizations for assessing pain during routine NICU procedures.

The intuition behind the method

The PIPP recognizes that preterm infants' pain responses are developmentally modified by gestational maturity; a behavioral response that indicates pain in a term infant may reflect normal prematurity-related immaturity in a 24-week-old. The scale incorporates gestational age (GA) as a weighting factor, adjusting expected behavioral and physiological responses downward for less mature infants. This developmental calibration increases sensitivity and specificity for pain detection across the wide gestational age range in neonatal populations. The tool balances behavioral cues (brow bulge, eye squeeze, nasolabial furrow) and physiological indicators (heart rate increase, oxygen saturation decrease) to capture pain responses even in deeply sedated or neurologically impaired infants.

History

The PIPP was developed by Bonnie Stevens and colleagues at the University of Toronto in 1996, addressing a critical gap in pain assessment for preterm infants. At that time, most neonatal pain scales were either too brief (single items) or designed for term infants, and preterm infants' developmentally attenuated pain responses were often unrecognized. The PIPP's inclusion of gestational age weighting was innovative. The original validation included 50 infants undergoing heel sticks; subsequent research (1998–2010) expanded validation to >1500 infants across multiple centers and procedures (venipuncture, lumbar puncture, intubation, extubation, suctioning). A revised version (PIPP-R) was published in 2014 with improved behavioral item definitions. The PIPP is now the most frequently cited neonatal pain scale in medical literature and is recommended by the American Academy of Pediatrics, International Association for the Study of Pain, and other major organizations.

When to use it

The PIPP is the gold-standard acute procedural pain assessment tool for preterm and term neonates undergoing painful procedures in the NICU or delivery room. It is specifically indicated for: (1) routine painful procedures (heel stick, venipuncture, lumbar puncture, chest tube placement, endotracheal intubation); (2) guiding acute analgesic/anesthetic interventions during procedures; (3) evaluating efficacy of pain management interventions (sucrose, non-nutritive sucking, opioids, topical anesthetics) in both clinical practice and research; (4) epidemiological research quantifying pain exposure in neonatal populations; (5) quality improvement initiatives documenting baseline pain management practices and tracking improvement after protocol implementation.

Limitations and considerations

  • Designed specifically for acute procedural pain; does not assess chronic or background pain in ventilated or post-operative infants over extended periods (use N-PASS or other tools for ongoing sedation assessment).
  • Vital sign indicators (heart rate, oxygen saturation) are confounded by non-pain factors: tachycardia and desaturation occur with sepsis, respiratory distress, cardiac disease, or even routine handling/diaper change, potentially inflating scores.
  • Facial expression scoring requires clear visualization; endotracheal tubes, ventilator interfaces, positioning, or anatomical variations may obscure brow bulge, eye squeeze, or nasolabial furrow, reducing item reliability.
  • Baseline heart rate and oxygen saturation are not established for all infants (e.g., in sick infants already tachycardic and hypoxemic), making percent-change calculations problematic.
  • Limited use in paralyzed or deeply sedated infants where behavioral items cannot be observed; in these populations, physiological items alone may miss pain or attribute non-pain tachycardia to pain.

Source conditions do not replace independent scientific review or validation by an analysis engine.

Strengths

  • Highest level of validation evidence among neonatal pain scales: >100 published studies across multiple international settings demonstrating strong psychometric properties (Cronbach's alpha 0.71–0.88, ICC 0.85–0.92).
  • Gestational age weighting increases developmental sensitivity, reducing false-positive pain detection in very preterm infants with developmentally immature behavioral responses.
  • Integrates behavioral (facial) and physiological (heart rate, oxygen saturation) indicators, improving pain detection accuracy across diverse clinical conditions including sedation or paralysis.
  • Rapid assessment (2–3 minutes) feasible in clinical workflow; requires no special equipment beyond standard vital sign monitoring.
  • Establishes pre- and post-intervention scores, quantifying analgesic effectiveness and supporting medication titration decisions.

Applications

  • Clinical acute pain assessment: Nurses and clinicians use PIPP to quantify pain during routine neonatal procedures, guiding analgesia/anesthesia decisions and ensuring consistent pain management across care team.
  • Analgesic efficacy evaluation: PIPP scores before and after pain management interventions (sucrose, opioid, topical anesthetic, non-nutritive sucking) provide objective evidence of intervention effectiveness, supporting education of staff and optimization of protocols.
  • Quality improvement and pain prevention research: NICUs use PIPP as a metric in quality initiatives examining pain prevalence, pain management practices, and effectiveness of system-level changes (e.g., mandatory analgesia orders, parent presence during procedures).
  • Comparative effectiveness research: Randomized controlled trials employ PIPP to compare analgesic agents (morphine vs. fentanyl, sucrose vs. other non-pharmacological methods) and document superior approaches for specific procedures and populations.
  • Long-term outcomes research: Epidemiological studies use cumulative PIPP scores (total pain burden) during NICU stay as predictor variable for neurodevelopmental outcomes, examining relationship between untreated neonatal pain and later developmental delays.

How it works

How it works

1

The PIPP is assessed during or immediately after a brief painful procedure (e.g., heel stick, venipuncture, endotracheal suctioning). Assessment requires three observation periods: a 15-second baseline immediately before the procedure, a 30-second observation during the procedure, and a 5-second observation at the peak pain response during or within 30 seconds after the procedure. All seven indicators are scored from these observations. No special equipment beyond standard NICU vital sign monitors is required. Assessment takes approximately 2–3 minutes total and can be performed by any bedside clinician with brief training.

2

The PIPP has seven indicators scored as follows: (1) Gestational Age (contextual factor, not pain indicator): <28 weeks=4 points; 28–30 weeks=3 points; 30–32 weeks=2 points; 32–34 weeks=1 point; >34 weeks=0 points. (2) Behavioral State (baseline): Active/Awake or Crying=3 points; Quiet/Awake=2 points; Active/Sleep=1 point; Quiet/Sleep=0 points. (3) Brow Bulge (during/after procedure): None=0 points; Minimal=1 point; Moderate/Maximal=2 points. (4) Eye Squeeze (during/after): None=0 points; Minimal=1 point; Moderate/Maximal=2 points. (5) Nasolabial Furrow (during/after): None=0 points; Minimal=1 point; Moderate/Maximal=2 points. (6) Heart Rate Increase (percentage increase from baseline): 0–24%=0 points; 25–49%=1 point; ≥50%=2 points. (7) Oxygen Saturation Decrease (percentage decrease from baseline): 0–2.4%=0 points; 2.5–5%=1 point; ≥5%=2 points. Total PIPP score ranges from 0 to 21. Scoring is straightforward: sum all seven indicators.

3

PIPP scores are interpreted as: 0–6: Minimal or no pain (not likely experiencing significant pain). 7–12: Mild to moderate pain (infant likely experiencing pain; mild analgesia or comfort measures may be considered). 13–18: Moderate to severe pain (pain is clearly present; analgesic intervention is recommended). 19–21: Severe pain (urgent analgesic intervention is indicated). The score is used both to detect pain presence and to quantify severity, allowing clinicians to make medication decisions. Serial PIPP scores before and after analgesic administration (e.g., 2 minutes post-sucrose, post-opioid) demonstrate analgesic effectiveness. PIPP scores also support research documenting pain prevalence during routine NICU procedures and evaluating pain management interventions.

Common pitfalls

  • Over-reliance on vital sign changes without behavioral confirmation; tachycardia during venipuncture may reflect pain OR procedural stress, handling disturbance, or underlying infection; facial grimace should confirm pain interpretation.
  • Failure to establish accurate baseline before procedure; baseline heart rate assessed during crying or activity is artificially elevated, reducing ability to detect pain-related increase.
  • Misinterpreting gestational age adjustment as reducing pain concern in preterm infants; even low PIPP scores in very preterm infants may represent significant pain relative to their developmental capacity for response.
  • Single PIPP score without serial assessment; a single high score documents pain occurrence but does not guide medication titration; pre/post-intervention comparison is essential for clinical decision-making.
  • Applying PIPP to non-procedural pain contexts (chronic discomfort, post-operative background pain) where facial indicators become unreliable and sustained vital sign elevation is expected baseline.

Frequently asked questions

How does PIPP differ from N-PASS, and which should be used when?

PIPP is designed exclusively for acute procedural pain assessment (pain score 0–21; unidirectional); N-PASS assesses both pain and sedation on a bidirectional scale (-10 to +10) applicable to ongoing NICU monitoring. Use PIPP for acute procedures (heel stick, venipuncture, lumbar puncture); use N-PASS for serial monitoring of ventilated infants requiring sedation management. PIPP takes 2–3 minutes; N-PASS takes 1–2 minutes. In clinical practice, both scales may be used: PIPP during procedures, N-PASS for between-procedure monitoring.

What is a PIPP score of 11? Does that baby need pain medication?

A PIPP of 11 falls in the mild-to-moderate pain range (7–12). This suggests the infant is experiencing pain. Whether medication is indicated depends on clinical context: for a brief, necessary procedure, the clinician may decide comfort measures (sucrose, non-nutritive sucking, parental holding) are sufficient. For a procedure expected to be prolonged or repeated, analgesic medication (topical anesthetic, opioid) is recommended. Guidelines suggest analgesic intervention for PIPP ≥7; institutional protocols vary.

Can PIPP be used in a 24-week gestational age infant?

Yes. The gestational age adjustment (maximum 4 points) is specifically designed to increase accuracy in very preterm infants. At 24 weeks, the infant receives a GA adjustment of 4 points; this means scores below ~7 may still reflect absence of pain even though facial responses are minimal due to neurological immaturity. Facial indicators are often absent in infants <28 weeks, so reliance shifts toward heart rate and oxygen saturation changes. PIPP remains valid in extremely preterm infants but interpreters must understand that low PIPP scores do not automatically mean no pain—behavioral ceiling effects exist.

What if an infant is on a ventilator and their baseline heart rate is already 160 bpm?

Baseline heart rate should be assessed during a calm, non-painful state (e.g., during sleep or quiet wakefulness). If the infant is persistently tachycardic due to illness, sepsis, or respiratory distress, the current rate serves as the baseline, and pain-related increases are still detected. For example, if baseline is 160 and pain causes increase to 185 bpm (a 15.6% increase), this scores 0 points (0–24% is minimal increase). This is a known limitation of PIPP in severely ill infants; clinicians should integrate PIPP scores with behavioral observation and clinical judgment rather than relying solely on vital sign changes.

Related methods

Sources

  1. Stevens, B., Johnston, C., Petryshen, P., & Taddio, A. (1996). Premature Infant Pain Profile: Development and Initial Validation. Clinical Journal of Pain, 12(1), 13-22.

    Open DOI reference
    Copied.
  2. Stevens, B. J., Gibbins, S., Yamada, J., et al. (2014). Epidemiology and Management of Painful Procedures in Infants in Canadian Neonatal Intensive Care Units. Canadian Medical Association Journal, 186(6), E225-E234.

    Open publication reference
    Copied.